Manufacturers Life Insurance Company, The Mannkind Corp Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Mannkind Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 138,730 shares of MNKD stock, worth $973,884. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138,730

Previous 101,435 36.77%

Holding current value

$973,884

Previous $529,000 64.65%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.01 - $6.7 $186,847 - $249,876	37,295 Added 36.77%	138,730 $871,000
Q2 2024 Aug 14, 2024	BUY	$4.05 - $5.43 $13,664 - $18,320	3,374 Added 3.44%	101,435 $529,000
Q1 2024 May 14, 2024	SELL	$3.25 - $5.27 $116,645 - $189,145	-35,891 Reduced 26.79%	98,061 $444,000
Q4 2023 Feb 13, 2024	SELL	$3.34 - $4.29 $1,492 - $1,917	-447 Reduced 0.33%	133,952 $487,000
Q3 2023 Nov 15, 2023	BUY	$3.91 - $5.45 $115,849 - $161,478	29,629 Added 28.28%	134,399 $555,000
Q2 2023 Aug 11, 2023	BUY	$3.72 - $4.79 $26,646 - $34,310	7,163 Added 7.34%	104,770 $426,000
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $16,850 - $24,017	4,266 Added 4.37%	101,873 $417,000
Q4 2022 Aug 11, 2023	BUY	$3.02 - $5.37 $2,168 - $3,855	718 Added 0.74%	97,607 $514,000
Q4 2022 Feb 13, 2023	BUY	$3.02 - $5.37 $2,168 - $3,855	718 Added 0.74%	97,607 $514,000
Q3 2022 Aug 11, 2023	SELL	$2.99 - $4.35 $6,156 - $8,956	-2,059 Reduced 2.08%	96,889 $299,000
Q3 2022 Nov 03, 2022	SELL	$2.99 - $4.35 $6,156 - $8,956	-2,059 Reduced 2.08%	96,889 $299,000
Q2 2022 Aug 11, 2023	SELL	$2.67 - $4.77 $6,803 - $12,153	-2,548 Reduced 2.51%	98,948 $376,000
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $6,803 - $12,153	-2,548 Reduced 2.51%	98,948 $377,000
Q1 2022 Aug 11, 2023	SELL	$2.62 - $4.45 $987 - $1,677	-377 Reduced 0.37%	101,496 $373,000
Q1 2022 May 20, 2022	SELL	$2.62 - $4.45 $64,260 - $109,145	-24,527 Reduced 19.46%	101,496 $374,000
Q4 2021 Feb 16, 2022	SELL	$4.05 - $5.37 $9,784 - $12,973	-2,416 Reduced 1.88%	126,023 $551,000
Q3 2021 Nov 12, 2021	SELL	$3.89 - $5.48 $40,518 - $57,079	-10,416 Reduced 7.5%	128,439 $559,000
Q2 2021 Aug 12, 2021	BUY	$3.61 - $5.45 $34,825 - $52,576	9,647 Added 7.47%	138,855 $757,000
Q1 2021 May 03, 2021	SELL	$3.14 - $6.14 $15,426 - $30,165	-4,913 Reduced 3.66%	129,208 $506,000
Q4 2020 Feb 12, 2021	BUY	$1.79 - $4.04 $4,761 - $10,746	2,660 Added 2.02%	134,121 $420,000
Q2 2020 Aug 10, 2020	BUY	$0.94 - $2.21 $6,327 - $14,875	6,731 Added 5.4%	131,461 $238,000
Q1 2020 May 15, 2020	BUY	$0.84 - $1.76 $8,370 - $17,538	9,965 Added 8.68%	124,730 $128,000
Q4 2019 Feb 14, 2020	SELL	$1.14 - $1.49 $12,338 - $16,126	-10,823 Reduced 8.62%	114,765 $148,000
Q3 2019 Nov 12, 2019	SELL	$1.04 - $1.44 $483 - $669	-465 Reduced 0.37%	125,588 $157,000
Q2 2019 Aug 14, 2019	BUY	$1.09 - $1.88 $18,032 - $31,102	16,544 Added 15.11%	126,053 $145,000
Q1 2019 May 13, 2019	BUY	$1.14 - $2.25 $18,624 - $36,758	16,337 Added 17.53%	109,509 $216,000
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $4,828 - $9,704	-4,734 Reduced 4.84%	93,172 $99,000
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $14,760 - $32,004	-14,614 Reduced 12.99%	97,906 $179,000
Q2 2018 Aug 14, 2018	BUY	$1.59 - $2.38 $173,642 - $259,917	109,209 Added 3298.37%	112,520 $214,000
Q1 2018 May 15, 2018	SELL	$2.28 - $3.8 $1,062 - $1,770	-466 Reduced 12.34%	3,311 $8,000
Q4 2017 Feb 08, 2018	BUY	$2.28 - $6.71 $6,602 - $19,432	2,896 Added 328.72%	3,777 $9,000
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $1,013 - $2,017	881	881 $2,000

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Mannkind Corp Transaction History